Cargando…
Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration
BACKGROUND: Prostate cancer (PCa) is a leading cause of cancer-related death in men. Sodium phenylbutyrate (SPB) has shown its potential as an anticancer therapy in numerous cancer types. In the present study, we attempted to assess the effect of SPB against PCa and whether this treatment was associ...
Autores principales: | Xu, Yawen, Zheng, Shaobo, Chen, Binshen, Wen, Yong, Zhu, Shanwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869668/ https://www.ncbi.nlm.nih.gov/pubmed/27274278 http://dx.doi.org/10.2147/OTT.S101794 |
Ejemplares similares
-
IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells
por: Xu, Yawen, et al.
Publicado: (2016) -
Clinical and Experimental Applications of Sodium Phenylbutyrate
por: Iannitti, Tommaso, et al.
Publicado: (2012) -
Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
por: Koganti, Raghuram, et al.
Publicado: (2022) -
A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate
por: Köse, Melis, et al.
Publicado: (2017) -
Effect of sodium 4-phenylbutyrate on Clenbuterol-mediated muscle growth
por: Brown, David M., et al.
Publicado: (2018)